We are live on ! Find out more
Brown Advisory

Brown Advisory Portfolio holdings

AUM $60.9B
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$79.6B
AUM Growth
+$3.14B
Cap. Flow
-$261M
Cap. Flow %
-0.33%
Top 10 Hldgs %
28.43%
Holding
1,306
New
82
Increased
428
Reduced
567
Closed
48

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$652M
2
TEAM icon
Atlassian
TEAM
+$615M
3
BX icon
Blackstone
BX
+$497M
4
EL icon
Estee Lauder
EL
+$201M
5
NOW icon
ServiceNow
NOW
+$153M

Sector Composition

Rank Sector Weight
1 Technology 32.84%
2 Financials 17.52%
3 Healthcare 12.51%
4 Industrials 9.88%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
201
Coca-Cola
KO
$354B
$56.8M 0.07%
790,342
+9,228
+1% +$632K
TNC icon
202
Tennant Co
TNC
$1.5B
$56.5M 0.07%
588,411
+75,379
+15% +$7.36M
SIBN icon
203
SI-BONE Inc
SIBN
$737M
$56M 0.07%
4,003,748
-143,013
-3% -$2.15M
SEIC icon
204
SEI Investments
SEIC
$11.9B
$55.8M 0.07%
805,755
-35,199
-4% -$2.35M
CG icon
205
Carlyle Group
CG
$16.3B
$55.7M 0.07%
1,294,669
-113,035
-8% -$4.74M
EPRT icon
206
Essential Properties Realty Trust
EPRT
$6.99B
$55.7M 0.07%
1,630,265
+5,906
+0.4% +$182K
SON icon
207
Sonoco
SON
$5.76B
$55.6M 0.07%
1,018,374
IWD icon
208
iShares Russell 1000 Value ETF
IWD
$82B
$55.4M 0.07%
292,006
-1,490
-0.5% -$271K
BPMC
209
DELISTED
Blueprint Medicines
BPMC
$54.9M 0.07%
593,768
-24,224
-4% -$2.41M
ACWI icon
210
iShares MSCI ACWI ETF
ACWI
$32.6B
$54.3M 0.07%
454,181
-60,847
-12% -$6.97M
TEAM icon
211
Atlassian
TEAM
$22B
$53.9M 0.07%
339,223
-3,741,506
-92% -$615M
IEMG icon
212
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$52.2M 0.07%
909,102
+6,867
+0.8% +$372K
MAS icon
213
Masco
MAS
$16B
$52.2M 0.07%
621,462
-89,077
-13% -$6.75M
ST icon
214
Sensata Technologies
ST
$6.65B
$51.9M 0.07%
1,446,537
+544,546
+60% +$20.3M
AGO icon
215
Assured Guaranty
AGO
$3.78B
$51.8M 0.07%
651,854
+11,721
+2% +$924K
MUSA icon
216
Murphy USA
MUSA
$11.3B
$51.5M 0.06%
104,591
-27,691
-21% -$13.9M
WK icon
217
Workiva
WK
$2.94B
$51.2M 0.06%
647,276
-373,402
-37% -$28M
AMT icon
218
American Tower
AMT
$77.7B
$50.8M 0.06%
218,505
-5,846
-3% -$1.3M
PCVX icon
219
Vaxcyte
PCVX
$7.89B
$50.7M 0.06%
444,039
+76,822
+21% +$6.92M
DOV icon
220
Dover
DOV
$27.2B
$49.5M 0.06%
258,018
-8,094
-3% -$1.47M
APO icon
221
Apollo Global Management
APO
$70.7B
$48.7M 0.06%
389,612
+1,855
+0.5% +$214K
BHVN icon
222
Biohaven
BHVN
$2.16B
$48.4M 0.06%
+968,359
New +$37.7M
ONB icon
223
Old National Bancorp
ONB
$10.1B
$47.8M 0.06%
2,560,367
+364,355
+17% +$6.82M
LIN icon
224
Linde
LIN
$237B
$47.3M 0.06%
99,246
+591
+0.6% +$270K
FLS icon
225
Flowserve
FLS
$9.25B
$46.7M 0.06%
903,498
-28,160
-3% -$1.36M

Similar funds

Brown Advisory's Q3 2024 Portfolio in Review

As of Q3 2024, Brown Advisory held 1,306 positions worth $79.6B, up 4.1% from $76.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown Advisory's Q3 2024 filing shows 82 new, 428 increased, 567 reduced and 48 closed positions. Its largest new stake was Talen Energy Corp: 626,841 shares worth $112M. The largest sale was Edwards Lifesciences, an estimated $652M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.

  • Brown Advisory's largest Q3 2024 buy was Talen Energy Corp: 626,841 shares worth $112M.
  • Brown Advisory added most to Ares Management in Q3 2024, an estimated $482M increase.
  • Brown Advisory's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $652M.
  • Brown Advisory fully exited Blackrock in Q3 2024, selling an estimated $66.6M.
  • Brown Advisory's ten largest holdings make up 28% of its $79.6B portfolio in Q3 2024.
  • Brown Advisory opened 82 new positions and closed 48 in Q3 2024.
  • Brown Advisory's portfolio value rose 4.1% quarter-over-quarter to $79.6B.

Based on Brown Advisory's 13F filing for Q3 2024, filed 13 Nov 2024.